LBI-HTA - Publications - Search - [Erbitux®/Cetuximab for metastatic colorectal cancer]

Wild, C. (2005): [Erbitux®/Cetuximab for metastatic colorectal cancer]. HTA-Newsletter 40: 2-3.

[img]
Preview
PDF (HTA-Newsletter 40) - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
124Kb

Official URL: http://hw.oeaw.ac.at/ita/hta-newsletter?frames=yes


Item Type:HTA Newsletter Item
Keywords:Erbitux, cetuximab, monoclonal antibody, metastatic colorectal cancer, second-line treatment, combination therapy
Subjects:WI Digestive system > WI 400-560 Intestines
QW Microbiology. Immunology
WB Practice of medicine > WB 340-356 Drug Administration
Related URLs:
References:1. London Cancer Drugs 2005: Cetuximab. URL: http://www.druginfozone.nhs.uk/
Record%20Viewing/viewRecord.aspx?id=553474.

2. EMEA 2004: Cetuximab. URL: http://www.emea.eu.int/humandocs/PDFs/EPAR/
erbitux/089404de1.pdf.

3. HAYES Alert 2004: Erbitux approved by FDA to treat subset of patients with colorectal cancer.

4. NHSC/GB 2002: Cetuximab for head and neck and colorectal cancer – horizon scanning review. URL: http://pcpoh.bham.ac.uk/publichealth/horizon/
PDF_files/2002reports/Cetuximab.pdf.
Language:German
Number:40
Deposited on:25 Feb 2008 20:07
Last Modified:09 Sep 2010 17:33

Repository Staff Only: item control page